IPHA's Revised Code of Practice for the Pharmaceutical Industry
Taking effect on 1 March 2021, the IPHA have revised their Code of Practice for the Pharmaceutical Industry

 

In January 2021, in addition to revising the Self-Care Advertising Code (see our article here), the Irish Pharmaceutical Healthcare Association (IPHA) released the latest edition (edition 8.5) of its Code of Practice for the Pharmaceutical Industry (Code), which will take effect on 1 March 2021 and applies to prescription-only medicines.

Various scandals within the pharmaceutical industry over the last few years involving pharmaceutical companies, doctors and hospitals, sparked a push to strengthen the existing Code. 

In our briefing we cover:

  • Key Changes
    • Inclusion of the EFPIA Ethical Principles
    • Transfers of Value Disclosures
    • Further Requirements Regarding Patient Organisation (PO) Funding
    • Definitions
    • Other Key Changes
  • Effect of the Code

Please click here or on the image below to download our briefing.

 

IPHAs Revised Code of Practice
 

Contributed by Florence Meagher & Louise Murray